CANbridge Pharmaceuticals Investor Relations Material
Latest events
Study Update
CANbridge Pharmaceuticals
H1 2024
29 Aug, 2024
H2 2023
28 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CANbridge Pharmaceuticals Inc
Access all reports
CANbridge Pharmaceuticals Inc is a Chinese biopharmaceutical company focused on developing and commercializing treatments for rare diseases and cancer. The company engages in drug discovery, licensing, and clinical development, with a pipeline spanning gene therapy and biologics. It operates in both China and global markets through partnerships and R&D collaborations. The company is headquartered in Beijing, China, and its shares are listed on the HKEX.
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
1228
Country
🇨🇳 China